Biolife Solutions (BLFS) Cash from Investing Activities (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Cash from Investing Activities data on file, last reported at -$1.8 million in Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$1.8 million, up 93.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$46.2 million (down 247.37% YoY), and the FY2025 annual result was -$71.5 million, down 222.71% from the prior year.
• Cash from Investing Activities eased to -$1.8 million in Q1 2026 per BLFS's latest filing, from $1.1 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $73.6 million in Q4 2024 and troughed at -$39.5 million in Q2 2025.
• A 5-year average of -$3.3 million and a median of -$1.8 million in 2026 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities soared 1760.93% in 2024, then sank 12196.83% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at -$14.9 million in 2022, then surged by 126.57% to $4.0 million in 2023, then soared by 1760.93% to $73.6 million in 2024, then slumped by 98.46% to $1.1 million in 2025, then plunged by 260.95% to -$1.8 million in 2026.
• Business Quant data shows BLFS's Cash from Investing Activities at -$1.8 million in Q1 2026, $1.1 million in Q4 2025, and -$6.0 million in Q3 2025.